Cargando…

Limosilactobacillus reuteri DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial

Studies have shown that probiotics can decrease the symptoms of respiratory tract infections as well as increase antibody responses following certain vaccinations. We examined the effect of probiotic supplementation on anti-SARS-CoV-2 specific antibody responses upon SARS-CoV-2 infection as well as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forsgård, Richard A., Rode, Julia, Lobenius-Palmér, Karin, Kamm, Annalena, Patil, Snehal, Tacken, Mirriam G. J., Lentjes, Marleen A. H., Axelsson, Jakob, Grompone, Gianfranco, Montgomery, Scott, Brummer, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321188/ https://www.ncbi.nlm.nih.gov/pubmed/37401761 http://dx.doi.org/10.1080/19490976.2023.2229938

Ejemplares similares

Antibiofilm activity and NMR-based metabolomic characterization of cell-free supernatant of Limosilactobacillus reuteri DSM 17938
por: Vitale, Irene, et al.
Publicado: (2023)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Limosilactobacillus reuteri DSM 17938 reverses gut metabolic dysfunction induced by Western diet in adult rats
por: Abuqwider, Jumana, et al.
Publicado: (2023)

Application of ultrasound and microencapsulation on Limosilactobacillus reuteri DSM 17938 as a metabolic attenuation strategy for tomato juice probiotication
por: Giordano, Irene, et al.
Publicado: (2022)

Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
por: Lavalle, Luca, et al.
Publicado: (2023)

Non-inhibitory levels of oxygen during cultivation increase freeze-drying stress tolerance in Limosilactobacillus reuteri DSM 17938
por: Rao, Nikhil Seshagiri, et al.
Publicado: (2023)

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants
por: Kaban, Risma K., et al.
Publicado: (2019)

Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938
por: Grande, Rossella, et al.
Publicado: (2017)

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
por: Urbańska, Magdalena, et al.
Publicado: (2014)

Human Skin Bacterial Community Response to Probiotic (Lactobacillus reuteri DSM 17938) Introduction
por: Frerejacques, Marie, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis
por: Butler, Éile, et al.
Publicado: (2020)

Effect of Microencapsulation on Survival at Simulated Gastrointestinal Conditions and Heat Treatment of a Non Probiotic Strain, Lactiplantibacillus plantarum 48M, and the Probiotic Strain Limosilactobacillus reuteri DSM 17938
por: Malmo, Clorinda, et al.
Publicado: (2021)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis
por: Gutiérrez-Castrellón, Pedro, et al.
Publicado: (2017)

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938
por: Hernández, Armando, et al.
Publicado: (2019)

The role of Lactobacillus reuteri DSM 17938 for the absorption of iron preparations in children with iron deficiency anemia
por: Manoppo, Jeanette, et al.
Publicado: (2019)

Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
por: Gupta, Nitasha, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis
por: Sung, Valerie, et al.
Publicado: (2014)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis: Erratum
Publicado: (2018)

Human Breast Milk Promotes the Secretion of Potentially Beneficial Metabolites by Probiotic Lactobacillus reuteri DSM 17938
por: Mai, Tu T., et al.
Publicado: (2019)

Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update
por: Patro-Gołąb, Bernadeta, et al.
Publicado: (2019)

Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice
por: West, Christine L., et al.
Publicado: (2020)

Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study
por: Cui, Xuewei, et al.
Publicado: (2019)

In Silico Genomic and Metabolic Atlas of Limosilactobacillus reuteri DSM 20016: An Insight into Human Health
por: Smythe, Paisleigh, et al.
Publicado: (2022)

Limosilactobacillus reuteri in Health and Disease
por: Abuqwider, Jumana, et al.
Publicado: (2022)

Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial
por: Kołodziej, Maciej, et al.
Publicado: (2017)

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial
por: Szymański, Henryk, et al.
Publicado: (2017)

Human Breast Milk Promotes the Immunomodulatory Function of Probiotic Lactobacillus reuteri DSM 17938 in the Neonatal Rat Intestine
por: Hoang, Thomas K, et al.
Publicado: (2019)

Assessment of the efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32203 for dogs (NBF LANES)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659
por: Sendelius, Malin, et al.
Publicado: (2023)

Lactobacillus reuteri DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic
por: Savino, Francesco, et al.
Publicado: (2019)

Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial
por: Mangalat, Nisha, et al.
Publicado: (2012)

The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Man, et al.
Publicado: (2015)

Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility
por: Indrio, Flavia, et al.
Publicado: (2017)

Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by Lactobacillus reuteri DSM 17938
por: Maccelli, Alessandro, et al.
Publicado: (2020)

Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial
por: Kubota, Megumi, et al.
Publicado: (2020)

A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea
por: Sun, Xiaoqi, et al.
Publicado: (2023)

Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
por: Piccioni, Andrea, et al.
Publicado: (2021)

454 Pyrosequencing Analysis on Faecal Samples from a Randomized DBPC Trial of Colicky Infants Treated with Lactobacillus reuteri DSM 17938
por: Roos, Stefan, et al.
Publicado: (2013)

Lactobacillus reuteri DSM 17938 Changes the Frequency of Foxp3(+) Regulatory T Cells in the Intestine and Mesenteric Lymph Node in Experimental Necrotizing Enterocolitis
por: Liu, Yuying, et al.
Publicado: (2013)

Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial
por: Romani Vestman, Nelly, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_doqbqu5flmdghuasnpaormbhc8